{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:16:47Z","timestamp":1793236607948,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jcmgh.2017.03.004","type":"journal-article","created":{"date-parts":[[2017,3,14]],"date-time":"2017-03-14T10:16:38Z","timestamp":1489486598000},"page":"75-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Gastrin and Gastric Cancer"],"prefix":"10.1016","volume":"4","author":[{"given":"Jill P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3290-4018","authenticated-orcid":false,"given":"Sandeep","family":"Nadella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Osborne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2017.03.004_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib2","doi-asserted-by":"crossref","first-page":"13637","DOI":"10.3748\/wjg.v20.i38.13637","article-title":"Medical management of gastric cancer: a 2014 update","volume":"20","author":"Elimova","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib3","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/djn517","article-title":"The impact of underreported Veterans Affairs data on national cancer statistics: analysis using population-based SEER registries","volume":"101","author":"Howlader","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib5","first-page":"CD004064","article-title":"Chemotherapy for advanced gastric cancer","volume":"3","author":"Wagner","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib6","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2011.36.2236","article-title":"Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study","volume":"29","author":"Ohtsu","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","article-title":"Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial","volume":"14","author":"Lordick","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib10","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1200\/JCO.2006.05.9758","article-title":"Disparities in gastric cancer chemotherapy between the East and West","volume":"24","author":"Ohtsu","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib11","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/SLA.0b013e3181d3d29b","article-title":"Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram","volume":"251","author":"Strong","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3748\/wjg.v12.i3.354","article-title":"Epidemiology of gastric cancer","volume":"12","author":"Crew","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ng.152","article-title":"Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer","volume":"40","author":"Sakamoto","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1753-4887.2008.00029.x","article-title":"Nutrition and gastric cancer risk: an update","volume":"66","author":"Liu","year":"2008","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/jso.23262","article-title":"Gastric cancer epidemiology and risk factors","volume":"107","author":"Guggenheim","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib19","doi-asserted-by":"crossref","first-page":"e74976","DOI":"10.1371\/journal.pone.0074976","article-title":"Helicobacter pylori infection synergizes with three inflammation-related genetic variants in the GWASs to increase risk of gastric cancer in a Chinese population","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/CEJ.0b013e3283656380","article-title":"Association of the IL-1B\u00a0+3954 C\/T polymorphism with the risk of gastric cancer in a population in Western China","volume":"23","author":"Wen","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib21","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/gut.2003.022061","article-title":"Clinical implications of E-cadherin associated hereditary diffuse gastric cancer","volume":"53","author":"Fitzgerald","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib22","first-page":"1139","article-title":"Receptors that regulate gastric acid-secretory function","author":"Soll","year":"1994"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1210\/endo-106-1-323","article-title":"Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin","volume":"106","author":"Dembinski","year":"1980","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib24","first-page":"G135","article-title":"Gastric mucosal cell proliferation during development in rats and effects of pentagastrin","volume":"242","author":"Majumdar","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/00365529109093190","article-title":"Trophic effects of gastrin","volume":"180","author":"Hakanson","year":"1991","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib26","first-page":"611","article-title":"Regulation of gastrointestinal mucosal growth","author":"Johnson","year":"1994"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0167-0115(00)00176-2","article-title":"Gastrin as a growth factor in the gastrointestinal tract","volume":"93","author":"Koh","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib28","first-page":"853","article-title":"HCl secretion by the gastric oxyntic cell","author":"Forte","year":"1987"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOG.0b013e32834bd53f","article-title":"Gastric secretion","volume":"27","author":"Schubert","year":"2011","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2036.1990.tb00457.x","article-title":"Serum gastrin levels during long-term omeprazole treatment","volume":"4","author":"Koop","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib31","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(93)90344-C","article-title":"Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis","volume":"104","author":"Lamberts","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/00365528909091254","article-title":"Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine","volume":"166","author":"Brunner","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0016-5085(90)90946-X","article-title":"Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis","volume":"99","author":"Jansen","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib34","first-page":"366","article-title":"Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients","volume":"39","author":"Lazzaroni","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/SMJ.0b013e31826efbea","article-title":"Proton pump inhibitors: the good, the bad, and the unwanted","volume":"105","author":"Chubineh","year":"2012","journal-title":"South Med J"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1586\/17512433.2013.811206","article-title":"Perils and pitfalls of long-term effects of proton pump inhibitors","volume":"6","author":"Wilhelm","year":"2013","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2017.03.004_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000200509","article-title":"Role of gastrin as a trophic hormone","volume":"47","author":"Walsh","year":"1990","journal-title":"Digestion"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0306-3623(98)00221-3","article-title":"Rat stomach ECL cells up-date of biology and physiology","volume":"32","author":"Chen","year":"1999","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1097\/01.pas.0000163363.86099.9f","article-title":"Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder","volume":"29","author":"Abraham","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib40","first-page":"411","article-title":"Characterization of CCK-B\/gastrin-like receptors in human gastric carcinoma","volume":"12","author":"Smith","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib41","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/bjc.1989.112","article-title":"Gastrin: growth enhancing effects on human gastric and colonic tumor cells","volume":"59","author":"Watson","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib42","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/TROG_20113203_175","article-title":"Proton pump inhibitors: concerns over prolonged use","volume":"32","author":"Mouli","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib43","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1007\/s10620-006-9419-3","article-title":"Chronic hypergastrinemia: causes and consequences","volume":"52","author":"Orlando","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib44","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3748\/wjg.v19.i16.2560","article-title":"Acid suppressive drugs and gastric cancer: a meta-analysis of observational studies","volume":"19","author":"Ahn","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13324","article-title":"Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology","volume":"42","author":"Lundell","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib46","first-page":"159","article-title":"Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin","volume":"66","author":"Han","year":"2015","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib47","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11894-012-0293-1","article-title":"Gastrin receptor pharmacology","volume":"14","author":"Dockray","year":"2012","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00014.2005","article-title":"Cholecystokinin and gastrin receptors","volume":"86","author":"Dufresne","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib49","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/gut.42.6.795","article-title":"Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines","volume":"42","author":"McWilliams","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.7150\/ijbs.14952","article-title":"The role of gastrin and CCK receptors in pancreatic cancer and other malignancies","volume":"12","author":"Smith","year":"2016","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib51","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cellsig.2007.08.016","article-title":"Gastrin transactivates the chromogranin A gene through MEK-1\/ERK- and PKC-dependent phosphorylation of Sp1 and CREB","volume":"20","author":"Cramer","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1196\/annals.1294.010","article-title":"Molecular mechanisms of gastrin-dependent gene regulation","volume":"1014","author":"Hocker","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0016-5085(99)70231-3","article-title":"Gastrin induces heparin-binding epidermal growth factor-like growth factor in rat gastric epithelial cells transfected with gastrin receptor","volume":"116","author":"Miyazaki","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib54","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1158\/0008-5472.CAN-05-3246","article-title":"Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor","volume":"66","author":"Dickson","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib55","doi-asserted-by":"crossref","first-page":"G992","DOI":"10.1152\/ajpgi.00206.2002","article-title":"Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC\/EGFR-dependent mechanism","volume":"286","author":"Sinclair","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib56","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1053\/j.gastro.2010.08.003","article-title":"TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa","volume":"139","author":"Quante","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib57","doi-asserted-by":"crossref","first-page":"G1726","DOI":"10.1152\/ajpgi.00348.2006","article-title":"Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways","volume":"292","author":"Tu","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib58","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1038\/sj.onc.1205999","article-title":"Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cells","volume":"21","author":"Bierkamp","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib59","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/MOG.0000000000000213","article-title":"Functional anatomy and physiology of gastric secretion","volume":"31","author":"Schubert","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib60","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1210\/en.2016-1270","article-title":"Zinc ions mediate gastrin expression, proliferation, and migration downstream of the cholecystokinin-2 receptor","volume":"157","author":"Chang","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2005.06.025","article-title":"Gastrin and cancer: a review","volume":"238","author":"Ferrand","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib62","doi-asserted-by":"crossref","first-page":"G1244","DOI":"10.1152\/ajpgi.00460.2011","article-title":"Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis","volume":"302","author":"Fino","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2007.06.017","article-title":"Role of gastrin peptides in carcinogenesis","volume":"257","author":"Grabowska","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib64","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nrc2014","article-title":"Gastrin - active participant or bystander in gastric carcinogenesis?","volume":"6","author":"Watson","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0303-7207(93)90135-7","article-title":"Evidence for autocrine growth stimulation by a gastrin\/CCK-like peptide of the gastric cancer HGT-1 cell line","volume":"93","author":"Remy-Heintz","year":"1993","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib66","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/bbrc.1998.9964","article-title":"Sp1 phosphorylation by Erk 2 stimulates DNA binding","volume":"254","author":"Merchant","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib67","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/febs.13148","article-title":"Sp1 and the 'hallmarks of cancer'","volume":"282","author":"Beishline","year":"2015","journal-title":"FEBS J"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib68","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3109\/00365521.2013.783101","article-title":"Characterization of gastrins and their receptor in solid human gastric adenocarcinomas","volume":"48","author":"Goetze","year":"2013","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib69","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1046\/j.1365-2168.2001.01716.x","article-title":"Expression of gastrin in developing gastric adenocarcinoma","volume":"88","author":"Henwood","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00432-005-0043-y","article-title":"Expression of gastrin and its receptor in human gastric cancer tissues","volume":"132","author":"Hur","year":"2006","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.peptides.2016.03.016","article-title":"PAI-1 deficiency increases the trophic effects of hypergastrinemia in the gastric corpus mucosa","volume":"79","author":"Fossmark","year":"2016","journal-title":"Peptides"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib72","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1038\/sj.onc.1208407","article-title":"Chronic gastritis in the hypochlorhydric gastrin-deficient mouse progresses to adenocarcinoma","volume":"24","author":"Zavros","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib73","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2014-307190","article-title":"CCK2R identifies and regulates gastric antral stem cell states and carcinogenesis","volume":"64","author":"Hayakawa","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrc.2016.24","article-title":"Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?","volume":"16","author":"Hayakawa","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coph.2016.08.013","article-title":"Gastrin and upper GI cancers","volume":"31","author":"Hayakawa","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib76","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2174\/156802607780960492","article-title":"CCK receptors and cancer","volume":"7","author":"Baldwin","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib77","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib78","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1007\/s10620-014-3468-9","article-title":"Gastrin may mediate the carcinogenic effect of Helicobacter pylori infection of the stomach","volume":"60","author":"Waldum","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib79","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.gastro.2015.01.040","article-title":"Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits","volume":"148","author":"Graham","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib80","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01869-15","article-title":"Helicobacter pylori diversity and gastric cancer risk","volume":"7","author":"Cover","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib81","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s10120-011-0044-2","article-title":"Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK\/ERK and JAK2-signaling pathways in gastric cancer cells","volume":"14","author":"Zhou","year":"2011","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00042737-200012060-00011","article-title":"Helicobacter pylori increases gastrin release from cultured canine antral G-cells","volume":"12","author":"Beales","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib83","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.31.5.522","article-title":"Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori","volume":"31","author":"Smith","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2017.00001","article-title":"Gastrin and gastric cancer","volume":"8","author":"Waldum","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib85","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1007\/BF02090363","article-title":"Gastrin receptor genes are expressed in gastric parietal and enterochromaffin-like cells of Mastomys natalensis","volume":"39","author":"Asahara","year":"1994","journal-title":"Dig Dis Sci"},{"issue":"Suppl","key":"10.1016\/j.jcmgh.2017.03.004_bib86","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1046\/j.1440-1746.2000.02145.x","article-title":"Mechanism of gastric mucosal proliferation induced by gastrin","volume":"15","author":"Kinoshita","year":"2000","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib87","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1016\/S0021-9258(19)39132-X","article-title":"Complete nucleotide sequence of human reg gene and its expression in normal and tumoral tissues. The reg protein, pancreatic stone protein, and pancreatic thread protein are one and the same product of the gene","volume":"265","author":"Watanabe","year":"1990","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0046-8177(94)90275-5","article-title":"Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin","volume":"25","author":"Bordi","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/00365529109093191","article-title":"Trophic effect of histamine on the stomach","volume":"180","author":"Waldum","year":"1991","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib90","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/apm.12380","article-title":"Hypergastrinemia is associated with adenocarcinomas in the gastric corpus and shorter patient survival","volume":"123","author":"Fossmark","year":"2015","journal-title":"APMIS"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2012.12.030","article-title":"Gastrin acting on the cholecystokinin2 receptor induces cyclooxygenase-2 expression through JAK2\/STAT3\/PI3K\/Akt pathway in human gastric cancer cells","volume":"332","author":"Xu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib92","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.regpep.2007.08.007","article-title":"Pre-clinical evaluation of a new orally-active CCK-2R antagonist, Z-360, in gastrointestinal cancer models","volume":"146","author":"Grabowska","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib93","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.2174\/156802607780960519","article-title":"Role of CCK\/gastrin receptors in gastrointestinal\/metabolic diseases and results of human studies using gastrin\/CCK receptor agonists\/antagonists in these diseases","volume":"7","author":"Berna","year":"2007","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.suronc.2012.06.004","article-title":"Cholecystokinin and gastrin receptors targeting in gastrointestinal cancer","volume":"21","author":"Rai","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib95","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.bjc.6603058","article-title":"Gastrazole (JB95008), a novel CCK2\/gastrin receptor antagonist, in the treatment of advanced pancreatic cancer: results from two randomised controlled trials","volume":"94","author":"Chau","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib96","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/bcp.13146","article-title":"Netazepide, a gastrin\/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis","volume":"83","author":"Boyce","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib97","first-page":"1612","article-title":"Role of gastrin and gastrin receptors on the growth of a transplantable mouse colon carcinoma (MC-26) in BALB\/c mice","volume":"46","author":"Singh","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib98","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0016-5085(88)80075-1","article-title":"Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer","volume":"95","author":"Smith","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib99","first-page":"R797","article-title":"Characterization of the CCK-B\/gastrin-like receptor in human colon cancer","volume":"271","author":"Smith","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib100","first-page":"488","article-title":"Clinical significance of gastrin receptors in human colon cancers","volume":"49","author":"Upp","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib101","first-page":"2840","article-title":"Gastrin in human bronchogenic carcinomas: constant expression but variable processing of progastrin","volume":"49","author":"Rehfeld","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib102","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0167-0115(91)90027-E","article-title":"CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium","volume":"32","author":"Smith","year":"1991","journal-title":"Regul Pept"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib103","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/BF01536744","article-title":"Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990","volume":"35","author":"Smith","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib104","first-page":"R135","article-title":"Identification of gastrin as a growth peptide in human pancreatic cancer","volume":"268","author":"Smith","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ijc.2910610216","article-title":"Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5","volume":"61","author":"Watson","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib106","first-page":"880","article-title":"Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer","volume":"56","author":"Watson","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib107","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<248::AID-IJC14>3.0.CO;2-G","article-title":"A\u00a0comparison of an anti-gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice","volume":"81","author":"Watson","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib108","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.45.6.812","article-title":"A\u00a0comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine\/paracrine gastrin mediated growth","volume":"45","author":"Watson","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib109","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1002\/cncr.21814","article-title":"An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: the GC4 study","volume":"106","author":"Ajani","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2017.03.004_bib110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejso.2004.03.009","article-title":"A\u00a0phase II study of G17DT in gastric carcinoma","volume":"30","author":"Gilliam","year":"2004","journal-title":"Eur J Surg Oncol"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X17300504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X17300504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:12:41Z","timestamp":1750104761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X17300504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2352345X17300504"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2017.03.004","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrin and Gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2017.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}